EP3126361
CHROMENE AND 1,1A,2,7B-TETRAHYDROCYCLOPROPA[C]CHROMENE PYRIDOPYRAZINEDIONES AS GAMMA-SECRETASE MODULATORS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
18.3.2015EP published:
6.11.2019EP application number:
15714951.9
EPO information:
European Patent Register
Max expiry date:
17.3.2035
Title:
CHROMENE AND 1,1A,2,7B-TETRAHYDROCYCLOPROPA[C]CHROMENE PYRIDOPYRAZINEDIONES AS GAMMA-SECRETASE MODULATORS
Timeline
Today
18.3.2015EP application
6.11.2019EP Publication
Owner
Name:
Pfizer Inc.Address:
235 East 42nd Street, 10017, New York, NY, US
Inventor
Name:
AM ENDE, Christopher WilliamAddress:
Mystic, Connecticut, US
Name:
HUMPHREY, John MichaelAddress:
Mystic, Connecticut, US
Name:
JOHNSON, Douglas ScottAddress:
Concord, Massachusetts, US
Name:
KAUFFMAN, Gregory WayneAddress:
East Greenwich, Rhode Island, US
Name:
PETTERSSON, Martin YoungjinAddress:
Littleton, Massachusetts, US
Name:
RANKIC, Danica AntoniaAddress:
Niantic, Connecticut, US
Name:
STEPAN, Antonia FriederikeAddress:
Brookline, Massachusetts, US
Name:
VERHOEST, Patrick RobertAddress:
Newton, Massachusetts, US
Priority
Number:
201461973436 PDate:
1.4.2014Country:
US
Classification
Categories:
C07D 471/04, A61K 31/4985, A61P 25/28